Correlation Between MeiraGTx Holdings and Effector Therapeutics

Can any of the company-specific risk be diversified away by investing in both MeiraGTx Holdings and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MeiraGTx Holdings and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MeiraGTx Holdings PLC and Effector Therapeutics, you can compare the effects of market volatilities on MeiraGTx Holdings and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MeiraGTx Holdings with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MeiraGTx Holdings and Effector Therapeutics.

Diversification Opportunities for MeiraGTx Holdings and Effector Therapeutics

-0.44

Correlation Coefficient

MeiraGTx Holdings  Effector Therapeutics

Very good diversification

The 3 months correlation between MeiraGTx and Effector is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding MeiraGTx Holdings PLC and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and MeiraGTx Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MeiraGTx Holdings PLC are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of MeiraGTx Holdings i.e., MeiraGTx Holdings and Effector Therapeutics go up and down completely randomly.

Pair Corralation between MeiraGTx Holdings and Effector Therapeutics

Given the investment horizon of 90 days MeiraGTx Holdings PLC is expected to generate 0.47 times more return on investment than Effector Therapeutics. However, MeiraGTx Holdings PLC is 2.12 times less risky than Effector Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Effector Therapeutics is currently generating about -0.06 per unit of risk. If you would invest  838.00  in MeiraGTx Holdings PLC on October 23, 2024 and sell it today you would lose (212.00) from holding MeiraGTx Holdings PLC or give up 25.3% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	72.47%
Values	Daily Returns

MeiraGTx Holdings PLC  vs.  Effector Therapeutics

MeiraGTx Holdings PLC

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in MeiraGTx Holdings PLC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, MeiraGTx Holdings may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Effector Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Effector Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Effector Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with MeiraGTx Holdings and Effector Therapeutics

The main advantage of trading using opposite MeiraGTx Holdings and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MeiraGTx Holdings position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.

The idea behind MeiraGTx Holdings PLC and Effector Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.